Skip to main content

Industry News

Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.

Emergent BioSolutions Expands Anthrax Vaccine Manufacturing Capabilities

Published 7/11/2010

Emergent BioSolutions was awarded a contract by the Department of Health and Human Services to expand anthrax vaccine production at its facility in Lansing, Mich. The contract was awarded by the Office of the Biomedical Advanced Research and Development Authority and will increase manufacturing capacity to 26 million doses per year. The value of the contract is estimated at $107 million over five years.

Read More

Purdue University Renovates Lilly Hall

Published 7/11/2010

Purdue University will begin construction in September of 2010 on a $5.5 million renovation of Lilly Hall’s west wing. The project will upgrade HVAC systems and replace windows and the passenger elevator. The general contractor for the renovation is J.R. Kelly Co. Inc. of Lafayette, Ind. Completion is expected in July of 2011.

Read More

Connecticut College Plans Science Center

Published 7/11/2010

Connecticut College will renovate and expand New London Hall to create a state-of-the-art science center in New London, Conn. Designed by Payette, the $20 million project will provide 23,673 nsf of collaborative research and teaching space for the departments of computer science and life sciences. Groundbreaking is expected in spring of 2011 with occupancy in fall of 2012. The interdisciplinary facility will house research and teaching labs, classrooms, computer labs, a greenhouse, and an electron microscopy suite.

Read More

Concorde Gruppe and Healthcare of Today Partner on Stem Cell Facility

Published 7/11/2010

Concorde Gruppe GmbH is partnering with Healthcare of Today to build a €50 million stem cell research and treatment facility in Adunatii Copaceni, Romania. Completion is expected in mid-2012. The facility will utilize patient stem cells in medical treatments and will promote innovation in the development of advanced stem cell therapies.

Read More

President Obama Issues Executive Order On Select Agent Regulations

Published 7/10/2010

President Barack Obama issued an executive order in July of 2010 requiring federal agencies to institute changes in the current implementation of the Select Agent Program and Regulations. The order directs federal agencies to take actions to improve the overall coordination, consolidation, and oversight of select agents and toxins (SAT).

Read More